Understanding the delayed onset of action of azathioprine in IBD: are we there yet?

Imke Atreya
March 2009
Gut;Mar2009, Vol. 58 Issue 3, p325
Academic Journal
No abstract available.


Related Articles

  • Update on Conventional Thiopurine Management in IBD. Hoentjen, Frank; de Boer, Nanne K. H. // Inflammatory Bowel Disease Monitor;2012, Vol. 12 Issue 4, p135 

    Conventional thiopurine therapy with azathioprine or 6-mercaptopurine is an important maintenance strategy in IBD. Unfortunately, many patients have to discontinue this therapy owing to adverse events or lack of efficacy. Given the limited options for alternative maintenance therapies in IBD, as...

  • IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Cannioto, Z.; Berti, I.; Martelossi, S.; Bruno, I.; Giurici, Nagua; Crovella, S.; Ventura, A.; Giurici, N // European Journal of Pediatrics;Feb2009, Vol. 168 Issue 2, p149 

    Inflammatory bowel disease (IBD) is uncommon in children younger than 2 years of age. The criteria for differentiating IBD from other diseases with similar clinical presentation is unclear. We describe 16 patients who, between 1984 and 2004, received a histological diagnosis of IBD during the...

  • The role of infection in the aetiology of inflammatory bowel disease. Hansen, Richard; Thomson, John; El-Omar, Emad; Hold, Georgina // Journal of Gastroenterology;Mar2010, Vol. 45 Issue 3, p266 

    We have greatly increased our understanding of the genetics of inflammatory bowel disease (IBD) in the last decade; however, migrant studies highlight the importance of environment in disease risk. The possibility that IBD is an infection has been debated since the first description of...

  • Qihoo 360 Tech, United Insurance Are Forming Bases. DAVID SAITO-CHUNG // Investors Business Daily;7/30/2014, pB03 

    Members of the IBD 50 showed mixed action Tuesday, yet some names still rose more than 1%.

  • Neutrophil anti-neutrophil cytoplasmic autoantibody proteins: bactericidal increasing protein, lactoferrin, cathepsin, and elastase as serological markers of inflammatory bowel and other diseases. Kyriakidi, Kallirroi S.; Tsianos, Vasileios E.; Karvounis, Evaggelos; Christodoulou, Dimitrios K.; Katsanos, Konstantinos H.; Tsianos, Epameinondas V. // Annals of Gastroenterology;2016, Vol. 29 Issue 3, p258 

    Infl ammatory bowel disease (IBD) is a chronic infl ammatory disorder of the gastrointestinal tract comprising Crohn's disease and ulcerative colitis. Although the pathogenesis of the disease is not clearly defi ned yet, environmental, genetic and other factors contribute to the onset of the...

  • Successful twin pregnancy in a patient with ulcerative colitis using azathoprine during conception. Casella, Giovanni; Villanacci, Vincenzo; Antonelli, Elisabetta; Di Bella, Camillo; Baldini, Vittorio; Nejad, Mohammad Rostami; Bassotti, Gabrio // Gastroenterology & Hepatology from Bed to Bench;Oct2011, Vol. 4 Issue 4, p224 

    Inflammatory bowel disease (IBD) frequently affects young patients of childbearing age. Treatments for inflammatory bowel disease include immunosuppressive, cytotoxic and surgical therapies. Azathioprine is frequently used to treat patients with steroid dependent IBD. We report the case of a...

  • Inflammatory Bowel Disease: Back to the Future. Sachar, David B. // American Journal of Gastroenterology;Apr1990, Vol. 85 Issue 4, p373 

    Discusses medicinal treatments and experimental models associated with inflammatory bowel disease (IBD). Techniques used in preparing mesalamine and mesalazine; Basis of the anti-inflammatory actions of hydrocortisone; Efficacy of azathioprine and 6-mercaptopurine; Reaction if IBD epithelial...

  • Risk of Cancer in Inflammatory Bowel Disease Treated With Azathioprine: A UK Population-Based Case–Control Study. Armstrong, Richard G.; West, Joe; Card, Timothy R. // American Journal of Gastroenterology;Jul2010, Vol. 105 Issue 7, p1604 

    OBJECTIVES:Azathioprine is an accepted treatment of inflammatory bowel disease (IBD), but concerns exist regarding its carcinogenic potential. Studies in renal transplant and rheumatology patients have reported an increased cancer risk. In IBD, studies suggest a small increased risk of lymphoma...

  • AWARENESS OF ADVERSE EFFECTS OF AZATHIOPRINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE -- MORE TO BE DONE? Spence, Andrew David Roy; Lee, Regina; Keegan, D.; Doherty, G. A.; Mulcahy, H.; Murphy, Seamus // Ulster Medical Journal;Jan2014, Vol. 83 Issue 1, p56 

    The article focuses on a study which assessed the proportion of inflammatory bowel disease (IBD) patients who received information regarding azathioprine and their understanding of adverse events. To gather information regarding patients' understanding of azathioprine and its adverse effects, a...

  • Geriatric Inflammatory Bowel Disease: Phenotypic Presentation, Treatment Patterns, Nutritional Status, Outcomes, and Comorbidity. Juneja, Manie; Baidoo, Leonard; Schwartz, Marc; Barrie, Arthur; Regueiro, Miguel; Dunn, Michael; Binion, David // Digestive Diseases & Sciences;Sep2012, Vol. 57 Issue 9, p2408 

    Background and Aims: The U.S. population is aging and the burden of geriatric inflammatory bowel disease (IBD) patients has increased. Systematic data describing phenotypic presentation, treatment regimens, outcomes and comorbidities in elderly IBD patients is limited. We performed a...


Read the Article


Sign out of this library

Other Topics